Presentation Information

[S6-04]Targeted radionuclide therapy via in-cell reaction with cancer metabolites

*Yudai Ode1, Akihiro Ishiwata1, Katsunori Tanaka1,2 (1. Biofunctional Synthetic Chemistry Laboratory, RIKEN Pioneering Research Institute (Japan), 2. School of Materials and Chemical Technology, Institute of Science Tokyo (Japan))